Clinical Trial Update: Rizatriptan for Episodic Dizziness in Vestibular Migraine [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for rizatriptan in episodic dizziness associated with vestibular migraine, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migrainous Vertigo
• Vestibular Migraine

Drugs mentioned

• Rizatriptan (Rizatriptan)

Snippet

Sponsor: Robert W. Baloh | Conditions: Vestibular Migraine, Migrainous Vertigo | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-11-04